229 related articles for article (PubMed ID: 28287186)
1. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis.
Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X
Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis.
Li X; Ma X; Chen L; Gu L; Zhang Y; Zhang F; Ouyang Y; Gao Y; Huang Q; Zhang X
Sci Rep; 2015 Aug; 5():13157. PubMed ID: 26287771
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
5. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y
Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.
Wang Z; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Cancer Manag Res; 2017; 9():679-689. PubMed ID: 29200888
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis.
Fan Y; Li H; Ma X; Gao Y; Chen L; Li X; Bao X; Du Q; Zhang Y; Zhang X
Medicine (Baltimore); 2015 Sep; 94(38):e1646. PubMed ID: 26402839
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis.
Zhou W; Zhang GL
PLoS One; 2019; 14(10):e0224266. PubMed ID: 31644587
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract][Full Text] [Related]
13. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
[TBL] [Abstract][Full Text] [Related]
15. Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
Xie Y; Li P; Gao Y; Gu L; Chen L; Fan Y; Zhang F; Zhang X
Oncotarget; 2017 Sep; 8(37):62489-62499. PubMed ID: 28977963
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis.
Liu Q; Zhang GW; Zhu CY; Wei JX; Tian X; Li Y; Li XD
Cancer Biomark; 2016; 16(2):281-9. PubMed ID: 26756619
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
[TBL] [Abstract][Full Text] [Related]
19. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
20. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.
Rashedi S; Mardani M; Rafati A; Khavandi MM; Mohammadi F; Javanshir S; Sarallah R; Dolatshahi M; Sabahi M; Azadnajafabad S; Tavolinejad H; Rezaei N
J Clin Lab Anal; 2022 Oct; 36(10):e24670. PubMed ID: 35989533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
